pharma · Dengue Fever · Chronic Babesiosis · SXTP
60 DEGREES PHARMACEUTICALS
60 DEGREES PHARMACEUTICALS, INC.
60 DEGREES PHARMACEUTICALS clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Washington, USA
- Founded
- 2010
- Employees
- 6
- Programs
- 5
- Drugs
- 2
- Patents
- 0
60 DEGREES PHARMACEUTICALS projects
5 ClinicalTrials.gov programs sponsored by 60 DEGREES PHARMACEUTICALS.
60 DEGREES PHARMACEUTICALS has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Celgosivir
60 DEGREES PHARMACEUTICALS, INC.
Dengue Fever
1 trial -
Tafenoquine
60 DEGREES PHARMACEUTICALS, INC.
Babesiosis
1 trial -
Tafenoquine
60 DEGREES PHARMACEUTICALS, INC.
Healthy Volunteers
1 trial -
Tafenoquine 100mg
60 DEGREES PHARMACEUTICALS, INC.
Chronic Babesiosis
1 trial -
Tafenoquine Oral Tablet
60 DEGREES PHARMACEUTICALS, INC.
COVID 19 Disease
1 trial
Frequently asked questions
How many clinical projects does 60 DEGREES PHARMACEUTICALS have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.